Relief Therapeutics Holding AG (RLFTF)

[tcm55]

NRXP, as the current Deal, hinges on the RLF-100. Everything does.
Shareholders of RLF FLOAT hold basically the only public interest of the MAIN thing. RLF-100.
Shareholders paid for R+D and Trials while NRX claimed managing the process.

THEY WILL WANT TO MAKE A BIG SPLASH ON NASDAQ as data is released. NO Strings...


"All development costs under the agreement are paid by Relief, providing NeuroRx with non dilutive development capital through drug approval"

Zyesami"
Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM"



NRXP will need to settle the ownership of RLF-100 for their deal. IMO Lawsuits question NRXP deal for High price and not having 100% control of RLF-100...

There should be No free ride for Dr JJ/NRX, IMO. No one will buy that company with just their PTSD drug, The 'PEARL' is RLF-100 and VIP Patents . Good Data makes everyone HAPPY. ALL IMO...GLTA...
"